Sofwave Medical Announces FDA Clearance of SUPERB™ Technology For Cellulite

SUPERB™ ANNOUNCEMENT! Sofwave™ has reached a new PEAK by receiving the U.S. Food and Drug Administration (FDA) clearance of an additional momentous indication for Sofwave's SUPERB™ technology to be used for the short-term improvement in the appearance of cellulite.

"We are pleased to receive FDA clearance to use the Company's proprietary SUPERB™ technology to improve the appearance of cellulite in the short term," said Dr. Shimon Eckhouse, Chairman of the Board and Co-founder of Sofwave™ Medical.

"The FDA's clearance of SUPERB™ for use in cellulite could not have come at a timelier moment. Our focused commitment across all markets will go a long way towards further accelerating global sales and brand recognition of our devices in the upcoming new year," said Sofwave™ Medical's Chief Executive Officer, Louis Scafuri.

To read the full press release: